Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
The latest announcement is out from Astec Lifesciences Limited ( (IN:ASTEC) ).
Astec LifeSciences Limited announced the outcome of its Rights Issue Committee meeting held on July 29, 2025, where they approved the allotment of 26,69,951 equity shares on a rights basis to eligible shareholders at a price of ₹890 per share. This move increases the company’s paid-up equity share capital from 1,96,11,710 to 2,22,81,661 shares, potentially strengthening its financial position and market standing.
More about Astec Lifesciences Limited
Astec LifeSciences Limited operates in the chemical industry, primarily focusing on the production and distribution of agrochemical products. The company is known for its expertise in manufacturing a range of crop protection chemicals and has a significant presence in the agrochemical market.
Average Trading Volume: 4,197
Technical Sentiment Signal: Sell
Current Market Cap: 19.49B INR
See more data about ASTEC stock on TipRanks’ Stock Analysis page.